Fast-Growing Akron-Based Tech Firm Recognized as a Top Workplace for Employees AKRON, Ohio–(BUSINESS WIRE)–#ai–Drips announced today it has been awarded a Northeast Ohio Top Workplaces 2022 honor by cleveland.com and The Plain Dealer. The list is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage, LLC. The … [Read more…]
NEW YORK–(BUSINESS WIRE)–Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the Food and Drug Administration (FDA) has placed a partial clinical hold on the Company’s Phase 1 dose escalation study of NUV-422 in solid tumors, including high … [Read more…]
OTTAWA, Ontario–(BUSINESS WIRE)–$BWXT–BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has executed a commercial agreement with Bayer AG (Bayer) to supply high-purity Actinium-225 (Ac-225). Today’s announcement follows the agreement reached by the two companies in September 2021. Under the terms of the commercial agreement, Bayer will purchase high-purity Ac-225 from BWXT … [Read more…]
− Fibrosis regression observed in 58% (7 of 12) of patients receiving 200 mg fazirsiran − Median reduction of 83% of Z-AAT accumulation in the liver − Reduction of 69% in histologic globule burden − Substantial and sustained improvements in clinically relevant biomarkers of liver health OSAKA, Japan & PASADENA, Calif.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) (“Takeda”) and … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Molecular Diagnostics Partnering Terms and Agreements 2015 to 2022” report has been added to ResearchAndMarkets.com’s offering. Key benefits In-depth understanding of Molecular Diagnostics deal trends since 2015 Access to headline, upfront, milestone and royalty data Detailed access to actual Molecular Diagnostics contracts entered into by leading biopharma companies Identify most active Molecular … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Sarcoidosis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. Report Highlights In the coming years, Sarcoidosis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Vietnam Software as a Service Market, By Business Application (Marketing, Customer Relationship Management, Others), By Offering, By Organization Size, By Deployment, By End User, By Region, Competition Forecast & Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. Vietnam Software as a Service market is anticipated to grow at a significant rate during … [Read more…]
STRASBOURG, France–(BUSINESS WIRE)–Braintale, a medtech deciphering white matter, spin off from the Paris Greater Hospitals has presented the results of SOM-ALS sub-study in amyotrophic lateral sclerosis (ALS) during the European Academy of Neurology (EAN 2022) congress both in Vienna (Austria) and digitally from June 25th to 28th, 2022. Long underestimated in neurosciences, white matter, which … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Ultra large Volume Wearable Injectors Market (2022-2027) by Product, Application, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Ultra large Volume Wearable Injectors Market is estimated to be USD 2.34 Bn in 2022 and is projected to reach USD 4.54 … [Read more…]
SINGAPORE–(BUSINESS WIRE)–#CancerTreatment–Prestige Biopharma Limited, a Singapore-based biopharmaceutical company with operations in USA and South Korea, announced that the U.S. Food and Drug Administration (FDA) has approved the Phase 1/2a clinical trial of its first-in-class anti-PAUF monoclonal antibody, PBP1510 (INN: Ulenistamab), for the treatment of pancreatic cancer. The clinical trial will be conducted on patients with … [Read more…]
